Four-year survival follow-up of toripalimab (JS001) as salvage therapy in Chinese melanoma patients.Bixia Tang,Zhihong Chi,Yingbo Chen,Xiufeng Liu,Di Wu,Jing Chen,Xin Song,Weifeng Wang,Lihou Dong,Haifeng Song,Hai Wu,Shukui Qin,Jun Guo,Xiaoshi Zhang,Sheng Yao,Hui FengJOURNAL OF CLINICAL ONCOLOGY(2021)引用 2|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要